3

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Form
Filing Date
May 17, 2021
Document Date
May 10, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
KemPharm
Issuer
KEMPHARM, INC
Filer
BRAUN SAMUEL J